ATC Group: L02AE04 Triptorelin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of L02AE04 in the ATC hierarchy

Level Code Title
1 L Antineoplastic and immunomodulating agents
2 L02 Endocrine therapy
3 L02A Hormones and related agents
4 L02AE Gonadotropin releasing hormone analogues
5 L02AE04 Triptorelin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code Route Amount Notes
PAREN Parenteral 0.1 mg
PAREN Parenteral 134 mg (depot)

Active ingredients in L02AE04

Active Ingredient

Triptorelin is a decapeptide analogue of GnRH which initially stimulates release of pituitary gonadotropins.

Related product monographs

Document Type Information Source  
 DECAPEPTYL SR Powder and solvent for suspension for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 DECAPEPTYL SR Powder for suspension for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 DIPHERELINE Powder and solvent for suspension for injection MPI, EU: SmPC Pharmaceutical Benefits Scheme (AU)
 GONAPEPTYL DEPOT Powder and solvent for suspension for injection prolonged release MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 SALVACYL Powder and solvent for prolonged-release suspension for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 TRELSTAR Suspension for injection MPI, US: SPL/PLR FDA, National Drug Code (US)

United States medicines

Medicines classified under this ATC code globally

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.